Diabetes and COVID-19: Considerations and Clinical Management: Contemporary Endocrinology
Editat de Alyson K. Myersen Limba Engleză Paperback – 12 iun 2024
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology,infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine.
Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 640.68 lei 38-44 zile | |
Springer International Publishing – 12 iun 2024 | 640.68 lei 38-44 zile | |
Hardback (1) | 904.11 lei 38-44 zile | |
Springer International Publishing – 11 iun 2023 | 904.11 lei 38-44 zile |
Din seria Contemporary Endocrinology
- 5% Preț: 1121.99 lei
- 5% Preț: 674.95 lei
- 5% Preț: 1049.10 lei
- 5% Preț: 1036.49 lei
- 5% Preț: 1106.69 lei
- 5% Preț: 1089.68 lei
- 5% Preț: 1627.85 lei
- 5% Preț: 789.60 lei
- 5% Preț: 934.24 lei
- 5% Preț: 720.84 lei
- 5% Preț: 1105.77 lei
- 5% Preț: 1106.33 lei
- 5% Preț: 1609.14 lei
- 5% Preț: 1108.72 lei
- 5% Preț: 1440.16 lei
- 5% Preț: 1014.59 lei
- 5% Preț: 1110.17 lei
- 5% Preț: 1438.23 lei
- 5% Preț: 1100.30 lei
- 5% Preț: 1613.06 lei
- 5% Preț: 1113.11 lei
- 5% Preț: 1002.20 lei
- 5% Preț: 1434.54 lei
- 5% Preț: 1119.47 lei
- 5% Preț: 1650.72 lei
- 5% Preț: 1442.42 lei
- 5% Preț: 1042.35 lei
- 5% Preț: 743.69 lei
- 5% Preț: 1108.51 lei
- 5% Preț: 1613.94 lei
- 5% Preț: 1105.04 lei
- 5% Preț: 1435.85 lei
- 5% Preț: 1421.21 lei
- 5% Preț: 1735.90 lei
- 5% Preț: 1612.49 lei
- 5% Preț: 1111.26 lei
- 5% Preț: 1100.09 lei
- 5% Preț: 1405.70 lei
- 5% Preț: 1345.79 lei
- 5% Preț: 1106.50 lei
- 5% Preț: 1290.85 lei
- 5% Preț: 1430.52 lei
- 5% Preț: 1431.30 lei
Preț: 640.68 lei
Preț vechi: 674.39 lei
-5% Nou
Puncte Express: 961
Preț estimativ în valută:
122.61€ • 127.23$ • 102.48£
122.61€ • 127.23$ • 102.48£
Carte tipărită la comandă
Livrare economică 12-18 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783031285387
ISBN-10: 3031285387
Ilustrații: XVIII, 219 p. 23 illus., 21 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:2023
Editura: Springer International Publishing
Colecția Springer
Seria Contemporary Endocrinology
Locul publicării:Cham, Switzerland
ISBN-10: 3031285387
Ilustrații: XVIII, 219 p. 23 illus., 21 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:2023
Editura: Springer International Publishing
Colecția Springer
Seria Contemporary Endocrinology
Locul publicării:Cham, Switzerland
Cuprins
COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention.- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance.- Risk of COVID-19 in Persons with Diabetes.- Pathophysiology of Lung Dysfunction in Diabetes.- Diabetic kidney disease and COVID-19.- The Impact of COVID-19 on Diabetic Foot Ulcers.- Co-morbid obesity and its impact on diabetes and COVID-19.- Overview of Inpatient Mgt of Diabetes and COVID 19.- Management of critically ill persons with COVID-19 and diabetes.- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes.- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19).- COVID-19 Vaccination in Persons with Diabetes.- COVID-19 Vaccination in Persons with Diabetes.- Long-haul COVID Symptoms in Person with Diabetes.
Notă biografică
Alyson K. Myers, MD, Division of Endocrinology, Department of Medicine, Montefiore Einstein, Bronx, NY
Textul de pe ultima copertă
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine.
Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.
Caracteristici
Comprehensive review of diabetes and COVID-19 Discussion of both inpatient and outpatient management of diabetes and COVID-19 Authored by a diverse group of providers